Blogs

All
  • All
  • About us
  • Campaigning
  • Dementia info
  • Fundraising
  • Living with dementia
  • Our scientists
  • Our supporters
  • Research

Scientist Focus: Dr Elena Di Daniel

Dr Elena Di Daniel who is Head of Biology at the Alzheimer’s Research UK Oxford Drug  Discovery Institute (DDI).

Dementia risk reduction – supporting research to develop the evidence base

There is increasing recognition that a mixture of genetic, lifestyle and health factors are likely to contribute to whether someone develops dementia at a particular age.

CAstle RidE for Alzheimer’s

I’ve hated Alzheimer’s ever since it took my nan from us. Now, 12 years on, I finally decided to do something to fight back.

Five minutes of amazing: my journey through dementia

Chris Graham was diagnosed with early-onset Alzheimer’s in 2010, aged just 34. Below is an extract from his newly released book detailing his mammoth 16,000-mile cycle ride around North America and Canada raising £40,000 for Alzheimer’s Research UK. ‘Five Minutes of Amazing’ was written with writer Wendy Holden.

Hope for the future

It’s hard to believe that you can find a positive in knowing that you have a 50/50 chance of developing Alzheimer’s in your 40s but that’s just what happened to me almost five years ago.

Steel Wool

Having experienced dementia both personally and professionally Daryl is releasing her latest work of fiction, Steel Wool.

Treatments of tomorrow: Preparing for breakthroughs in dementia

Today we launched our new report Treatments of tomorrow: Preparing for breakthroughs in dementia. In it, we call for an urgent plan for managing how new medicines reach patients.

Preparing for a breakthrough: ‘A new treatment would be the greatest thing’

I support Alzheimer’s Research UK because I pin all hope that together we’ll be able to find a disease-modifying treatment to give more quality of life to millions like my Dad. The experience of losing Dad affects the way I plan my life because I know too well that mine can be snatched away at no notice and without explanation.

Chrissi and Ciana with dad Mike Ayre

Alzheimer’s stole my dad from me

Chrissi’s childhood was not like most. She became a carer at the age of 11 when her dad received a shocking diagnosis of early-onset Alzheimer’s disease.

Why I’m Running Down Dementia: I’ve never been so proud of myself

Richard Judd is a novice runner who lives with his wife in Leadgate, County Durham. He has two grown up children and has been supporting Alzheimer’s Research UK by taking part in the charity’s latest campaign Running Down Dementia around his busy job in telesales.

The Higher Education and Research Bill – what this could mean for dementia research

Today the Higher Education and Research Bill, which proposes changes to the structures and funding mechanisms for teaching and research in Universities, starts the next stage of its journey towards becoming law as it reaches committee stage in Westminster.

Fred and Joan Walker

Reading the signs – Fred’s story

Fred Walker’s wife Joan lived life to the full – it was one of the many things he loved about her. But in 2010, Alzheimer’s robbed Fred of his beloved wife. They had been married 46 years.

In the news: Aducanumab – new Alzheimer’s trial results announced

With 850,000 people currently living with dementia in the UK, and this number set to rise to over one million by 2025, urgency is building around dementia research and the hunt for new treatments that could benefit the millions of people around the world living with the condition.

Running Down Dementia

If you’re looking to get fit this summer, there’s no better motivation than Alzheimer’s Research UK’s latest challenge, Running Down Dementia.

#RDDSweatySelfie

Our #RunningDownDementia runners didn’t disappoint us. We’ve had hundreds of images on social media showing you in all your #RDDSweatySelfie glory.

42 countries, two wheels, one man

How far would you go to raise money for a good cause? Joss Livesey, a 25-year-old from Cumbria, is going over 13,000 miles.

Sixtyat60

Vivien Hunot retired after turning 60 in 2015. But instead of putting her feet up Vivien vowed to raise as much money as she could for Alzheimer’s Research UK by completing 60 tasks to mark the occasion.

Learning from cancer research in the hunt for dementia treatments

On the final day of last month’s Alzheimer’s Association International Conference in Toronto, we heard from Dr Jane Ann Driver, a cancer scientist who moved disciplines and took the leap into dementia research. This experience gave her a valuable perspective on dementia research, allowing her to impart lessons learned in cancer research and to highlight important similarities and differences between the two areas.

What Alzheimer’s Research UK supporters need to know about recent Government changes

It’s been hard to ignore how much political change has taken place in the UK recently. Following the EU Referendum and David Cameron’s resignation, Theresa May is our new Prime Minister – and this means lots of new cabinet members for Alzheimer’s Research UK to build relationships with.

Why I’m Racing the Tide to beat down dementia

I’ve got great support from two good friends who are joining me. In no particular order because these two guys are both solid as rocks.

Testing new apps that connect people with dementia and researchers

At Alzheimer’s Research UK we’re always looking for ways to help people get involved with dementia research. That’s why we’re supporting Dementia Citizens, a new initiative from innovation foundation Nesta and its partners Bangor University and Glasgow Caledonian University.

How I conquered an extreme marathon

Richard Bazeley completed one of the hardest marathons in the world for Alzheimer’s Research UK. On 21 May 2016 he embarked on The Great Wall Marathon in Beijing, China.

Researching risk reduction

While elements of risk might be set in stone, at the Alzheimer’s Association International Conference this week we’ve heard from researchers who are targeting elements of lifestyle that may alter our dementia risk, so called ‘modifiable risk factors’.

Behind the headlines: what’s the real story for LMTX?

Most of the news reports that focused on this possible silver lining did explain that the effect was only seen in a very small group of the people on the study – though this may not have been clear from some of the headlines people have seen today.

Silver lining for first anti-tau Alzheimer’s treatment in phase III?

Findings were reported today from the first phase III anti-tau drug in people with mild-to-moderate Alzheimer’s. The drug, called LMTM, was being tested in a 15-month double-blind, controlled trial in 891 people.